Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Thomas Jefferson University
OHSU Knight Cancer Institute
Albert Einstein College of Medicine
AIDS Malignancy Consortium
University of California, San Francisco
National Cancer Institute (NCI)
University of Washington
University of Maryland, Baltimore
City of Hope Medical Center
University of Washington
University of California, San Francisco
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California
National University Hospital, Singapore
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins